SwanBio Therapeutics
Chris Hollowood has been the Chairman of SwanBio’s Board of Directors since 2018. He also serves as the Chief Investment Officer of Syncona Investment Management Limited, part of Syncona Limited, a leading healthcare investment company focused on founding, building, and funding global leaders in life sciences
This person is not in the org chart
This person is not in any offices
SwanBio Therapeutics
With offices in Philadephia and Boston, SwanBio Therapeutics is developing leading-edge therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases.